Navigation Links
Eclipse Aesthetics, LLC Files Suit Against RegenLab USA, LLC
Date:7/23/2014

DALLAS, July 23, 2014 /PRNewswire/ -- On Tuesday, July 1, 2014, Eclipse Aesthetics, LLC ("Plaintiff") filed suit in the 116th Judicial District Court in Dallas, Texas, against RegenLab USA, LLC ("Defendant") for Tortious Interference with Current and Prospective Business Relationships through false and misleading actions, fraud, fraud-in-the-inducement, business interference, tortious interference; and, Business Disparagement through libel, disparagement, defamation, misrepresentation, and violating the false/deceptive advertising laws (among other laws) that are valid in every state in the United States.

Eclipse Aesthetics is a developer and supplier of aesthetic-based products for cosmetic procedures including Platelet Rich Plasma (Eclipse PRP™). RegenLab USA designs, develops, manufactures, and commercializes Platelet Rich Plasma (PRP) for professional markets.

As a result of RegenLab USA knowingly sending a false, fraudulent, and deceptive Promotional E-mail that was intentionally designed to disparage Eclipse and Eclipse PRP™ while damaging its standing within the medical care community, Eclipse has filed suit against RegenLab USA.

CONTACT: Info@eclipsemed.com, 800-759-6876

Logo - http://photos.prnewswire.com/prnh/20131203/LA27104LOGO


'/>"/>
SOURCE Eclipse Aesthetics, LLC
Copyright©2014 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse
2. MiMedx Files Its Initial Investigational New Drug Application
3. Valeant Pharmaceuticals Files Investor Presentation
4. ViaCyte Files Investigational New Drug Application and Device Master File with FDA for Novel Cell Replacement Therapy Product Candidate Designed to Treat Patients with Type 1 Diabetes
5. BioSpain 2014 Expands its Investment Forum Through Wider Range of Investor Profiles and more Participating Companies
6. Otonomy Files Registration Statement for Proposed Initial Public Offering
7. MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics
8. EntreMed Files New Drug Global Clinical Trial Application For ENMD-2076 With China CFDA
9. Flexion Therapeutics Files Registration Statement for Proposed Initial Public Offering
10. Ormco Corporation Files Appeal to the Federal Court Against Ortho Classic H4 Bracket Patent Infringement
11. Molecular Profiles Joins Leading Consortium To Drive Paediatric Formulation Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, ... a Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, ... winners, announced today online at www.diabetesscholars.org by ... 1 diabetes stand in the way of academic and ... the Foundation,s scholarship program since 2012, and continues to ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is ... a fitness app. The fitness app plans to fix the two major problems leading the ... one size fits all type program , They don’t eliminate all the reasons ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
Breaking Medicine News(10 mins):